Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.5M | 43 | 99.1% |
| Travel and Lodging | $11,914 | 13 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,600 | 1 | 0.1% |
| Food and Beverage | $206.90 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | $1.4M | 51 | $0 (2024) |
| Blueprint Medicines Corporation | $152,625 | 8 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $1,600 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159,640 | 5 | PUMA BIOTECHNOLOGY, INC. ($159,640) |
| 2023 | $318,995 | 14 | Puma Biotechnology, Inc. ($164,770) |
| 2022 | $150,788 | 5 | PUMA BIOTECHNOLOGY, INC. ($150,788) |
| 2021 | $368,677 | 5 | PUMA BIOTECHNOLOGY, INC. ($368,677) |
| 2020 | $288,023 | 5 | Puma Biotechnology, Inc. ($288,023) |
| 2019 | $156,109 | 19 | Puma Biotechnology, Inc. ($156,109) |
| 2018 | $65,979 | 7 | Puma Biotechnology, Inc. ($65,979) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | PUMA BIOTECHNOLOGY, INC. | — | Consulting Fee | Stock, stock option, or any other ownership interest | $89,640.00 | General |
| 10/01/2024 | PUMA BIOTECHNOLOGY, INC. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 07/02/2024 | PUMA BIOTECHNOLOGY, INC. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 04/02/2024 | PUMA BIOTECHNOLOGY, INC. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 01/02/2024 | PUMA BIOTECHNOLOGY, INC. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 11/17/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $24,000.00 | General |
| 10/20/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $22,500.00 | General |
| 10/02/2023 | Puma Biotechnology, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 08/31/2023 | Siemens Medical Solutions USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| 08/25/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| 08/04/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 07/28/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $30,000.00 | General |
| 07/03/2023 | Puma Biotechnology, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 06/30/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| 06/16/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 06/09/2023 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $31,125.00 | General |
| 04/03/2023 | Puma Biotechnology, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 01/03/2023 | Puma Biotechnology, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 01/01/2023 | Puma Biotechnology, Inc. | — | Consulting Fee | Stock, stock option, or any other ownership interest | $94,770.00 | General |
| 10/01/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Consulting Fee | In-kind items and services | $17,500.00 | General |
| Category: ONCOLOGY | ||||||
| 07/01/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Consulting Fee | In-kind items and services | $17,500.00 | General |
| Category: ONCOLOGY | ||||||
| 04/01/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Consulting Fee | In-kind items and services | $17,500.00 | General |
| Category: ONCOLOGY | ||||||
| 01/01/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Consulting Fee | Stock, stock option, or any other ownership interest | $80,788.20 | General |
| Category: ONCOLOGY | ||||||
| 01/01/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Consulting Fee | In-kind items and services | $17,500.00 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2021 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| Category: ONCOLOGY | ||||||
About Dr. Adrian Senderowicz, MD
Dr. Adrian Senderowicz, MD is a Medical Oncology healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396935649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrian Senderowicz, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $159,640 received in 2024. These payments were reported across 60 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($1.5M).
Practice Information
- Specialty Medical Oncology
- Location Bethesda, MD
- Active Since 08/01/2007
- Last Updated 08/14/2007
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396935649
Products in Payments
- NERLYNX (Drug) $807,488
- Nerlynx (Drug) $222,088
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Bethesda
Ralph Boccia, M.d, M.D
Medical Oncology — Payments: $4.3M
Dr. Richard Piekarz, Md, MD
Medical Oncology — Payments: $167,988
Dr. Lee Helman, Md, MD
Medical Oncology — Payments: $51,392
Victor Priego, M.d, M.D
Medical Oncology — Payments: $48,721
Dr. Christopher Klebanoff, M.d, M.D
Medical Oncology — Payments: $28,531
Christian Hinrichs, M.d, M.D
Medical Oncology — Payments: $17,331